We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidances on Trial Enrichment, Monitoring
FDA Issues Guidances on Trial Enrichment, Monitoring
The FDA released two clinical-related guidances on Thursday for sponsors of drugs and biologics, on enrichment of clinical trials and on risk-based monitoring.